Elena V. Yakovleva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elena V. Yakovleva has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Boris Evgenievich Borodulin
Samara State Medical University
17 shared publications - Lyudmila Povalyaeva
Federal State Budgetary Educational Institution of Higher Education “Samara State Medical University” of the Ministry of Healthcare of the Russian Federation
4 shared publications - A. E. Sukhanova
«Samara State Medical University» of the Ministry of Health of the Russian Federation
3 shared publications - Elizaveta Sergeevna Vdoushkina
Samara State Medical University
3 shared publications - Kristina Vasilievna Zhilinskaya
Samara State Medical University
3 shared publications - Andrey Nikolaevich Gerasimov
Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical and Biological Agency
2 shared publications
Latest Publications
- 14 May 2026
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 104 (2)
Analysis of Tuberculosis Fatal Risk Factors in the Patients Hospitalized with COVID-19
The objective: to analyze risk factors of the unfavorable course of tuberculosis detected in the patients hospitalized with suspected COVID-19. Subjects and Methods. Of 1079 patients hospitalized with suspected COVID-19 and pneumonia, 120 case histories of patients with tuberculosis were retrospectively selected using a continuous sampling method; the fatal outcome was reported in 17.5% of cases (21/120). Results. Chronic kidney disease, diabetes mellitus, and underweight were more common among patients with a fatal outcome. Of the laboratory data, the most significant risk factors for an unfavorable outcome were as follows: levels of hemoglobin below 110 g/l, total protein below 60.4 g/l, D-dimer above 2.21 μg/ml, and C-reactive protein above 91.9 mg/l.
- 14 May 2026
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 104 (2)
Analysis of Tuberculosis Fatal Risk Factors in the Patients Hospitalized with COVID-19
The objective: to analyze risk factors of the unfavorable course of tuberculosis detected in the patients hospitalized with suspected COVID-19. Subjects and Methods. Of 1079 patients hospitalized with suspected COVID-19 and pneumonia, 120 case histories of patients with tuberculosis were retrospectively selected using a continuous sampling method; the fatal outcome was reported in 17.5% of cases (21/120). Results. Chronic kidney disease, diabetes mellitus, and underweight were more common among patients with a fatal outcome. Of the laboratory data, the most significant risk factors for an unfavorable outcome were as follows: levels of hemoglobin below 110 g/l, total protein below 60.4 g/l, D-dimer above 2.21 μg/ml, and C-reactive protein above 91.9 mg/l.
- 26 February 2026
- Published by National Association of Phthisiatricians in Медицинский Альянс
Co-infections: COVID-19, tuberculosis, and HIV (review)
COVID-19 pandemic has sparked active discussion about the interactions between COVID-19, tuberculosis, and HIV. The purpose of the study is to conduct a comprehensive assessment of the immunological, clinical, and organiza-tional aspects of the interactions between COVID-19, tu-berculosis, and HIV, based on literature review. Materials and methods. This review study was conducted using a systematic search and analysis of scientific publications on the co-infections of COVID-19, tuberculosis, and HIV. A search for publications from 2020 to 2025 was con-ducted in the international electronic databases PubMed, Google Scholar, Scopus, and the Russian scientific elec-tronic library eLibrary.ru. Results. One of the main practi-cal challenges is the difficulty in distinguishing COVID-19 from tuberculosis due to similar symptoms, such as cough and fever. This often leads to a late diagnosis of one dis-ease in the presence of the other. The combined course of COVID-19 and tuberculosis, referred to as the «collision of two pandemics» is more severe and more than doubles the risk of death from COVID-19. From an immunological perspective, the combined course of infections disrupts the regulation of the inflammatory response. SARS-CoV-2 can disrupt a balanced immune response to tuberculo-sis infection, potentially triggering the reactivation of latent tuberculosis. Key mechanisms include cytokine imbalance (such as TNF-α, IFN-γ, and IL-6) and decreased T-lymphocyte count and function, which are necessary to control both infections. The presence of triple infection (COVID-19/TB/HIV) significantly worsens the prognosis. Furthermore, disruptions to healthcare systems during the pandemic have threatened years of progress in the fight against tuberculosis and HIV. Conclusion. Despite advances in understanding immune mechanisms, many issues related to the diagnosis and management of pa-tients with co-infections, especially in the presence of HIV, require further study.
- 26 February 2026
- Published by National Association of Phthisiatricians in Медицинский Альянс
Co-infections: COVID-19, tuberculosis, and HIV (review)
COVID-19 pandemic has sparked active discussion about the interactions between COVID-19, tuberculosis, and HIV. The purpose of the study is to conduct a comprehensive assessment of the immunological, clinical, and organiza-tional aspects of the interactions between COVID-19, tu-berculosis, and HIV, based on literature review. Materials and methods. This review study was conducted using a systematic search and analysis of scientific publications on the co-infections of COVID-19, tuberculosis, and HIV. A search for publications from 2020 to 2025 was con-ducted in the international electronic databases PubMed, Google Scholar, Scopus, and the Russian scientific elec-tronic library eLibrary.ru. Results. One of the main practi-cal challenges is the difficulty in distinguishing COVID-19 from tuberculosis due to similar symptoms, such as cough and fever. This often leads to a late diagnosis of one dis-ease in the presence of the other. The combined course of COVID-19 and tuberculosis, referred to as the «collision of two pandemics» is more severe and more than doubles the risk of death from COVID-19. From an immunological perspective, the combined course of infections disrupts the regulation of the inflammatory response. SARS-CoV-2 can disrupt a balanced immune response to tuberculo-sis infection, potentially triggering the reactivation of latent tuberculosis. Key mechanisms include cytokine imbalance (such as TNF-α, IFN-γ, and IL-6) and decreased T-lymphocyte count and function, which are necessary to control both infections. The presence of triple infection (COVID-19/TB/HIV) significantly worsens the prognosis. Furthermore, disruptions to healthcare systems during the pandemic have threatened years of progress in the fight against tuberculosis and HIV. Conclusion. Despite advances in understanding immune mechanisms, many issues related to the diagnosis and management of pa-tients with co-infections, especially in the presence of HIV, require further study.
- Open Access
- 8 August 2025
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 35 (4) , 522-529
Tuberculosis under the “mask” of coronavirus pneumonia during the decline of the COVID-19 pandemic
Periods of increased incidence of respiratory viral infections are associated with increased risk of misdiagnosing other diseases with respiratory symptoms, including tuberculosis.The purpose of the study is to analyze the problem of differential diagnosis of pulmonary tuberculosis during the COVID-19 pandemic. Methods. The study was conducted at a city hospital that accepts patients with suspected new coronavirus infection around the clock. Two groups were recruited over 12 months using the continuous sampling method. The first group included 21 patients who were diagnosed with newly developed pulmonary tuberculosis that was initially diagnosed as coronavirus, the second group included 37 patients treated with the diagnosis of a new coronavirus infection. Statistical data processing was performed in MedCalc 19.2.6. Statistical Software.Results. The percentage of men was higher in the group with tuberculosis. No statistically significant differences were found in the medical history. Statistically significant differences between the studied groups were observed in total bilirubin, total protein, C-reactive protein, fibrinogen, ESR, hemoglobin, erythrocytes, leukocytes, platelets, age, the presence of sputum, loss of smell. The logistic regression method was used. Stepwise elimination led to a model that presents the most significant six indicators which can be useful in the differential diagnosis of tuberculosis and coronavirus in patients with a negative PCR test for coronavirus: hemoglobin, fibrinogen, leukocytes, ESR, CRP, and the presence of sputum.Conclusion. Regardless of the current epidemiological situation for seasonal respiratory infections, tuberculosis does not lose its significance as an infectious disease that requires timely and competent differential diagnosis
- 8 August 2025
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 35 (4) , 522-529
Open AccessTuberculosis under the “mask” of coronavirus pneumonia during the decline of the COVID-19 pandemic
Periods of increased incidence of respiratory viral infections are associated with increased risk of misdiagnosing other diseases with respiratory symptoms, including tuberculosis.The purpose of the study is to analyze the problem of differential diagnosis of pulmonary tuberculosis during the COVID-19 pandemic. Methods. The study was conducted at a city hospital that accepts patients with suspected new coronavirus infection around the clock. Two groups were recruited over 12 months using the continuous sampling method. The first group included 21 patients who were diagnosed with newly developed pulmonary tuberculosis that was initially diagnosed as coronavirus, the second group included 37 patients treated with the diagnosis of a new coronavirus infection. Statistical data processing was performed in MedCalc 19.2.6. Statistical Software.Results. The percentage of men was higher in the group with tuberculosis. No statistically significant differences were found in the medical history. Statistically significant differences between the studied groups were observed in total bilirubin, total protein, C-reactive protein, fibrinogen, ESR, hemoglobin, erythrocytes, leukocytes, platelets, age, the presence of sputum, loss of smell. The logistic regression method was used. Stepwise elimination led to a model that presents the most significant six indicators which can be useful in the differential diagnosis of tuberculosis and coronavirus in patients with a negative PCR test for coronavirus: hemoglobin, fibrinogen, leukocytes, ESR, CRP, and the presence of sputum.Conclusion. Regardless of the current epidemiological situation for seasonal respiratory infections, tuberculosis does not lose its significance as an infectious disease that requires timely and competent differential diagnosis
- Open Access
- 25 June 2025
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 35 (3) , 434-441
Intrathoracic lymph node tuberculosis in pulmonological practice: clinical case
Intrathoracic lymph node tuberculosis (ITLNTB), or tuberculous bronchoadenitis, is increasingly diagnosed in middle aged patients in the era of spreading human immunodeficiency virus (HIV) infection. The difficulty of early diagnosis lies in the absence of specific symptoms at the initial stages of the disease. Often, the diagnosis can be verified only after complications develop.The aim of the study was to analyze a clinical case of diagnosing ITLNTB in the practice of a pulmonologist.Methods. The article presents the results of general clinical, laboratory, and instrumental research methods, and other materials of a patient with a long previous history of respiratory symptoms.Results. According to the results of the diagnostic minimum at the initial examination, no data for tuberculosis were found, and the antibacterial therapy for 7 days had no effect. Intoxication syndrome persisted. Computed tomography (CT) of the chest organs detected fistulas from the paratracheal lymph nodes to the esophagus and bronchi. Mycobacterium tuberculosis was detected in the bronchoalveolar lavage fluid using the Ziehl – Neelson staining method.Conclusion. Despite the modern extensive diagnostic capabilities, such as CT, fibrobronchoscopy (FBS), and fibrogastroduodenoscopy, the diagnosis of tuberculosis is still highly challenging due to the numerous “masks”, long-term latent development of symptoms, and clinical manifestations only with the development of a fistula. FBS is recognized as the primary method for diagnosing tuberculosis of the trachea and bronchi. It not only visualizes the mucosal lesion, but also allows obtaining material for microbiological and histological examination.
- 25 June 2025
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 35 (3) , 434-441
Open AccessIntrathoracic lymph node tuberculosis in pulmonological practice: clinical case
Intrathoracic lymph node tuberculosis (ITLNTB), or tuberculous bronchoadenitis, is increasingly diagnosed in middle aged patients in the era of spreading human immunodeficiency virus (HIV) infection. The difficulty of early diagnosis lies in the absence of specific symptoms at the initial stages of the disease. Often, the diagnosis can be verified only after complications develop.The aim of the study was to analyze a clinical case of diagnosing ITLNTB in the practice of a pulmonologist.Methods. The article presents the results of general clinical, laboratory, and instrumental research methods, and other materials of a patient with a long previous history of respiratory symptoms.Results. According to the results of the diagnostic minimum at the initial examination, no data for tuberculosis were found, and the antibacterial therapy for 7 days had no effect. Intoxication syndrome persisted. Computed tomography (CT) of the chest organs detected fistulas from the paratracheal lymph nodes to the esophagus and bronchi. Mycobacterium tuberculosis was detected in the bronchoalveolar lavage fluid using the Ziehl – Neelson staining method.Conclusion. Despite the modern extensive diagnostic capabilities, such as CT, fibrobronchoscopy (FBS), and fibrogastroduodenoscopy, the diagnosis of tuberculosis is still highly challenging due to the numerous “masks”, long-term latent development of symptoms, and clinical manifestations only with the development of a fistula. FBS is recognized as the primary method for diagnosing tuberculosis of the trachea and bronchi. It not only visualizes the mucosal lesion, but also allows obtaining material for microbiological and histological examination.
- Open Access
- 18 August 2024
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 34 (4) , 478-486
Characteristics of patients with sarcoidosis that was diagnosed using invasive methods
Sarcoidosis is a multisystem disease of unknown origin that is characterized by formation of granulomas in various organs, predominantly lungs and lymph nodes. The approaches to evaluation and treatment of patients with sarcoidosis are controversial. Differential diagnosis of sarcoidosis is most often carried out with tuberculosis (TB). The aim of the study was to determine the characteristics of patients with sarcoidosis diagnosed using invasive diagnostic methods and assessment of these characteristics for differential diagnosis with tuberculosis. Methods. The medical histories of patients admitted to the thoracic surgery department to verify the diagnosis of sarcoidosis were studied. Videothoracoscopy was chosen to obtain biopsy samples as the safest and the most valuable diagnostic procedure. Sarcoidosis was diagnosed when a characteristic granuloma was detected by pathology. Results. Of the 64 cases, 42 (65.6%) were women and 22 (34.4%) were men. The mean age was 48.4 ± 11.6 years. Of the 64 patients studied, 26 (40.6%) people had a preliminary diagnosis of tuberculosis. In 19 (73.1%) of these cases, tuberculosis was excluded by a tuberculosis specialis, and in 7 (26.9%) cases TB was excluded after the anti-tuberculosis treatment course. Baed on the histology, the most common types of sarcoidosis were pulmonary (30/64, 46.9%) and combined lymph node and pulmonary sarcoidosis 25 (39.1%). Sarcoidosis of the lymph nodes 5 (7.8%) and sarcoidosis of other locations 4 (6.3%) were much less common. The largest group of patients were women with sarcoidosis of the lymph nodes and lungs 20 (31.3%) aged 35–64 years. Conclusion. Diagnosis of sarcoidosis is difficult. When examining a patient with newly identified changes in the lungs and lymph nodes and dissemination syndrome, the anti-tuberculosis treatment not justified in the absence of convincing evidence for tuberculosis, a negative test for HIV infection, in the absence of inflammatory changes in the blood, in the presence of prolonged contact with dust and when the patient is female. Morphological verification of the diagnosis will reduce the time required for diagnosis and eliminate the incorrect prescription of chemotherapy.
- 18 August 2024
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 34 (4) , 478-486
Open AccessCharacteristics of patients with sarcoidosis that was diagnosed using invasive methods
Sarcoidosis is a multisystem disease of unknown origin that is characterized by formation of granulomas in various organs, predominantly lungs and lymph nodes. The approaches to evaluation and treatment of patients with sarcoidosis are controversial. Differential diagnosis of sarcoidosis is most often carried out with tuberculosis (TB). The aim of the study was to determine the characteristics of patients with sarcoidosis diagnosed using invasive diagnostic methods and assessment of these characteristics for differential diagnosis with tuberculosis. Methods. The medical histories of patients admitted to the thoracic surgery department to verify the diagnosis of sarcoidosis were studied. Videothoracoscopy was chosen to obtain biopsy samples as the safest and the most valuable diagnostic procedure. Sarcoidosis was diagnosed when a characteristic granuloma was detected by pathology. Results. Of the 64 cases, 42 (65.6%) were women and 22 (34.4%) were men. The mean age was 48.4 ± 11.6 years. Of the 64 patients studied, 26 (40.6%) people had a preliminary diagnosis of tuberculosis. In 19 (73.1%) of these cases, tuberculosis was excluded by a tuberculosis specialis, and in 7 (26.9%) cases TB was excluded after the anti-tuberculosis treatment course. Baed on the histology, the most common types of sarcoidosis were pulmonary (30/64, 46.9%) and combined lymph node and pulmonary sarcoidosis 25 (39.1%). Sarcoidosis of the lymph nodes 5 (7.8%) and sarcoidosis of other locations 4 (6.3%) were much less common. The largest group of patients were women with sarcoidosis of the lymph nodes and lungs 20 (31.3%) aged 35–64 years. Conclusion. Diagnosis of sarcoidosis is difficult. When examining a patient with newly identified changes in the lungs and lymph nodes and dissemination syndrome, the anti-tuberculosis treatment not justified in the absence of convincing evidence for tuberculosis, a negative test for HIV infection, in the absence of inflammatory changes in the blood, in the presence of prolonged contact with dust and when the patient is female. Morphological verification of the diagnosis will reduce the time required for diagnosis and eliminate the incorrect prescription of chemotherapy.
- 25 June 2022
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 11 (2)
Features Of Iron Metabolism In Patients With HIV Infection And Pulmonary Dissemination In Tuberculosis And Pneumonia: An Exploratory Case-Control Study
Background — Differential diagnosis of pneumonia vs. tuberculosis in patients with HIV infection and pulmonary dissemination syndrome is an important problem in contemporary clinical medicine. The goal of our study was to determine the features of iron metabolism in patients with HIV infection and pulmonary dissemination in tuberculosis and pneumonia. Methods — The case-control study was conducted on 42 cases (patients with tuberculosis, hereinafter referred to as Group 1) and 44 control subjects (patients with pneumonia, hereinafter referred to as Group 2). All of them had HIV infection and syndrome of pulmonary dissemination. For subjects in both groups, we analyzed clinical and social characteristics, along with laboratory data. We also examined hepcidin content, iron concentration, and ferritin level in blood serum, and performed statistical data processing. Findings — There were significant differences between cases and controls in terms of iron metabolism. Hepcidin and hemoglobin levels were statistically significantly higher (p <0·001), whereas iron concentration was lower (p=0·0002) in patients with tuberculosis (cases). Furthermore, there were statistically significant differences between groups in CD4+ T-cell count, viral load, and RBC and WBC counts in complete blood count tests; in duration of complaints prior to hospital admission; and in terms of job stability. Conclusion — The quantitative parameters with the greatest statistical significance of the differences between the groups were iron concentration, hepcidin level, RBC count, WBC count, and CD4+ T-cell count.
- 25 June 2022
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 11 (2)
Features Of Iron Metabolism In Patients With HIV Infection And Pulmonary Dissemination In Tuberculosis And Pneumonia: An Exploratory Case-Control Study
Background — Differential diagnosis of pneumonia vs. tuberculosis in patients with HIV infection and pulmonary dissemination syndrome is an important problem in contemporary clinical medicine. The goal of our study was to determine the features of iron metabolism in patients with HIV infection and pulmonary dissemination in tuberculosis and pneumonia. Methods — The case-control study was conducted on 42 cases (patients with tuberculosis, hereinafter referred to as Group 1) and 44 control subjects (patients with pneumonia, hereinafter referred to as Group 2). All of them had HIV infection and syndrome of pulmonary dissemination. For subjects in both groups, we analyzed clinical and social characteristics, along with laboratory data. We also examined hepcidin content, iron concentration, and ferritin level in blood serum, and performed statistical data processing. Findings — There were significant differences between cases and controls in terms of iron metabolism. Hepcidin and hemoglobin levels were statistically significantly higher (p <0·001), whereas iron concentration was lower (p=0·0002) in patients with tuberculosis (cases). Furthermore, there were statistically significant differences between groups in CD4+ T-cell count, viral load, and RBC and WBC counts in complete blood count tests; in duration of complaints prior to hospital admission; and in terms of job stability. Conclusion — The quantitative parameters with the greatest statistical significance of the differences between the groups were iron concentration, hepcidin level, RBC count, WBC count, and CD4+ T-cell count.
- Open Access
- 27 May 2022
- Published by Volgograd State Medical University in Bioethics journal
- Vol. 15 (1) , 58-62
Euthanasia and palliative care in pulmonology
Background: Currently, euthanasia is officially allowed only in a number of countries, in most countries, as well as in the Russian Federation, it is prohibited by law. However, in clinical practice, there are a large number of incurable patients who experience intractable pain, so the problem of euthanasia is relevant. Aim: to analyze the current state of the problem of euthanasia and palliative care in pulmonology. Material and methods: review of domestic and foreign literature on the problem of euthanasia over the past 10 years has been carried out. Literature search was carried out using the e-library and PubMed databases. Results: We present a medical and philosophical perspective. Currently, euthanasia (Greek "good death") is a way to quickly and painlessly die if there is a serious illness that is incurable, suffering and pain. The best and perhaps the only alternative to euthanasia is palliative care. In pulmonology, palliative care focuses on early detection of respiratory failure, dyspnea, fear and pain relief. The effective organization of palliative care in respiratory medicine depends on the well-coordinated work of pulmonologists, physiotherapists, nurses, and psychologists. Conclusion: The problem of euthanasia to date still remains controversial from both medical and ethical points of view. The adoption of euthanasia by law may be a deterrent to governments from funding research into new treatments. The risk of abuse of euthanasia in order to obtain organs for transplantation or to get rid of seriously ill burdensome relatives cannot be ruled out. It is necessary to consider the issue of introducing additional educational cycles on the issues of modern achievements in palliative medicine, technical means of rehabilitation and the peculiarities of their use in patients with various diseases in the terminal stage in the training of doctors and nurses.
- 27 May 2022
- Published by Volgograd State Medical University in Bioethics journal
- Vol. 15 (1) , 58-62
Open AccessEuthanasia and palliative care in pulmonology
Background: Currently, euthanasia is officially allowed only in a number of countries, in most countries, as well as in the Russian Federation, it is prohibited by law. However, in clinical practice, there are a large number of incurable patients who experience intractable pain, so the problem of euthanasia is relevant. Aim: to analyze the current state of the problem of euthanasia and palliative care in pulmonology. Material and methods: review of domestic and foreign literature on the problem of euthanasia over the past 10 years has been carried out. Literature search was carried out using the e-library and PubMed databases. Results: We present a medical and philosophical perspective. Currently, euthanasia (Greek "good death") is a way to quickly and painlessly die if there is a serious illness that is incurable, suffering and pain. The best and perhaps the only alternative to euthanasia is palliative care. In pulmonology, palliative care focuses on early detection of respiratory failure, dyspnea, fear and pain relief. The effective organization of palliative care in respiratory medicine depends on the well-coordinated work of pulmonologists, physiotherapists, nurses, and psychologists. Conclusion: The problem of euthanasia to date still remains controversial from both medical and ethical points of view. The adoption of euthanasia by law may be a deterrent to governments from funding research into new treatments. The risk of abuse of euthanasia in order to obtain organs for transplantation or to get rid of seriously ill burdensome relatives cannot be ruled out. It is necessary to consider the issue of introducing additional educational cycles on the issues of modern achievements in palliative medicine, technical means of rehabilitation and the peculiarities of their use in patients with various diseases in the terminal stage in the training of doctors and nurses.
- 1 January 2022
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 11 (3)
Features of the COVID-19 in lung tissue damage admitted to hospital
Особенности COVID-19 при поражении легочной ткани у поступающих на стационарное лечение
- 1 January 2022
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 11 (3)
Features of the COVID-19 in lung tissue damage admitted to hospital
Особенности COVID-19 при поражении легочной ткани у поступающих на стационарное лечение